Related Experiment Video

Updated: Oct 19, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Treatment options for coronary stent restenosis

H L Dauerman1, D J Cohen

  • 1Division of Cardiology, University of Massachusetts-Memorial, Medical Center, USA.

Comprehensive Therapy
|October 16, 1999
PubMed

Insights

Balloon angioplasty effectively treats focal in-stent restenosis. For diffuse cases, debulking procedures like atherectomy or laser significantly lower restenosis recurrence rates.

Area of Science:

  • Cardiovascular Interventions
  • Medical Device Technology

Background:

  • In-stent restenosis (ISR) is a significant complication after percutaneous coronary intervention.
  • Focal ISR can be managed with balloon angioplasty, but diffuse ISR has high recurrence rates.

Purpose of the Study:

  • To evaluate treatment strategies for diffuse in-stent restenosis.
  • To compare the efficacy of balloon angioplasty versus debulking techniques for diffuse ISR.

Main Methods:

  • Retrospective analysis of patients with in-stent restenosis.
  • Comparison of outcomes between balloon angioplasty alone and debulking procedures (atherectomy or laser) for diffuse ISR.

Main Results:

  • Balloon angioplasty alone for focal ISR is adequate.
  • Diffuse ISR treated with balloon angioplasty alone has a 50% recurrence rate.
  • Debulking with atherectomy or laser significantly reduces recurrence rates for diffuse ISR.

Conclusions:

  • For diffuse in-stent restenosis, debulking therapies are superior to balloon angioplasty alone.
  • Atherectomy or laser debulking should be considered for managing diffuse ISR to improve long-term outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...